Skip to content
Business Company News, Medical Health Aged Care

HeraMED Limited (ASX: HMD) Announces Live Implementation of HeraCARE at Broward Health, Florida

Jane Morgan Management 2 mins read


  • HeraCARE is now live at Broward Health, one of the largest public healthcare systems in the U.S.

  • The two-year agreement with Broward Health includes 700 HeraCARE licenses and 200 HeraBEAT devices.

  • The initial implementation has already registered 20 mothers, with plans to scale significantly.

  • The partnership aims to revolutionize maternal care with innovative telehealth solutions.

Melbourne, Australia - HeraMED Limited (ASX: HMD) ("HeraMED" or the "Company"), a leader in digital transformation of maternity care, is thrilled to announce the successful launch of its HeraCARE platform at Broward Health in Florida, USA. This marks a significant milestone as Broward Health becomes the first major U.S. healthcare system to implement HeraMED's remote monitoring solutions.

The initial rollout has seen 20 mothers onboarded, with plans to expand the implementation to support at least 700 pregnancies. This partnership, signed in February 2024, represents the largest deployment of remote monitoring solutions in the U.S. to date.

HeraMED Managing Director and CEO Anoushka Gungadin confirmed, “Working with Broward Health is hugely significant for HeraMED as we collaborate in an aligned vision to change maternity and pregnancy care and maternal outcomes. It is exciting to see the positive momentum and engagement with Broward mums as they experience the HeraCARE platform and HeraBEAT devices in their maternity care. We look forward to continuing to respond to the needs of Broward Health and mums, while supporting the delivery of the highest level of care, and provider-patient experience.” 

Rose McKelvie, Broward Health’s Associate Vice President of Women’s and Children’s Service Line added, “As part of the implementation, we have been impressed with the team at HeraMED including their focus on leading change in maternal care. Through the innovative technology brought to us via the innovative HeraCARE platform and its impressive configurability, we are delighted to be driving and leading the positive change in improving the health of expecting mothers as well as access to care during and after pregnancies at Broward Health.”

About us:

About HeraMED Limited:

HeraMED is an innovative medical data and technology company leading the digital transformation of maternity care by revolutionising the prenatal and postpartum experience with its hybrid maternity care platform. HeraMED offers a proprietary platform that utilises hardware and software to reshape the Doctor/Patient relationship using its clinically validated in-home foetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence, and big data. The Company’s proprietary offering, HeraCARE, has been engineered to offer a fully integrated maternal health ecosystem designed to deliver better care at a lower cost, ensure expectant mothers are engaged, informed and well-supported, allow healthcare professionals to provide the highest quality care and enable early detection and prevention of potential risks.


Contact details:

Jane Morgan


More from this category

  • Community, Medical Health Aged Care
  • 22/07/2024
  • 17:24
Odyssey Lifestyle Care Communities

Dancing and dining; seniors celebrate four fabulous years

Odyssey Lifestyle Care Communities recently celebrated a significant milestone in style, marking its fourth birthday with an evening full of fun, fantastic food and…

  • Contains:
  • Biotechnology, Medical Health Aged Care
  • 22/07/2024
  • 12:56

Research into psychedelic medicines to treat anxiety wins ANS Illumina Neurogenomics Award 2024

Genomic technologies to discover biological markers, within the blood, that could predict patient response to psychedelic medicines such as psilocybin. MELBOURNE, AUSTRALIA, 22 July 2024 - Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the winner of the annual Australasian Neuroscience Society (ANS) Illumina Neurogenomics Research Award as Dr Andrew Gibbons from the Department of Psychiatry, School of Clinical Sciences at Monash Health. “Psilocybin, a chemical produced by hallucinogenic mushrooms, is a psychedelic medicine that has shown to meaningfully reduce symptoms of generalized anxiety during psychotherapy for patients. However, not all patients respond.…

  • Contains:
  • Industrial Relations, Medical Health Aged Care
  • 22/07/2024
  • 11:12
Australian Nursing and Midwifery Federation (Victorian Branch)

Bolton Clarke nurses and carers to hold stop-work rally – Mon 22 July, 1pm-2pm

WHATANMF Bolton Clarke members two-hour stop work and community rally for fair pay and conditionsACTU Secretary Sally McManus and VTHC Secretary Luke Hilakari will address the rally WHENMonday, 22 July 2024, 1pm-3pm. (Speakers will start 1.05pm sharp) WHEREoutside Bolton Clarke’s Victorian headquarters, 347 Burwood Highway, Forest Hill Bolton Clarke nurses, personal care workers and midwives will stop work for two hours on Monday 22 July to rally for better pay and conditions. For the past 18 months, the Australian Nursing and Midwifery Federation (Victorian Branch) has been negotiating wages and conditions on behalf of about 1700 members working across Bolton…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.